Efficacy and Safety of Systematic Therapy and Bronchoscopic Interventional Treatment for Pulmonary Mucormycosis

NAEnrolling by invitationINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 30, 2024

Primary Completion Date

July 30, 2025

Study Completion Date

December 30, 2025

Conditions
Pulmonary Mucormycosis
Interventions
PROCEDURE

transbronchoscopic interventional debridement

"1. combination drug therapy:liposomal amphotericin B + posaconazole or Isavuconazole:3-5mg/kg/day+ Posaconazole 300 mg once daily; target blood trough concentration is \>1ug/mL; if posaconazole is unavailable, Isavuconazole 200 mg once daily may be an alternative.~2. transbronchoscopic local precision infusion of amphotericin B: Maximum dose not more than 30mg per session~3. transoral nebulized inhalation of amphotericin B:amphotericin B 10mg + 5ml of sterilized water for injection, inhalation 2/day.~4)transbronchoscopic interventional debridement"

Trial Locations (1)

Unknown

Beijing TsingHua ChangGung hospital, Beijing

All Listed Sponsors
lead

Beijing Tsinghua Chang Gung Hospital

OTHER